Ibag, Rheann A.
HRN: 25-35-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/25/2024
07/02/2024
IV
360 Mg
Q 6 Hours
AGE; PCAP
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes